Skip to Main Content



To learn more about cancer survivorship research at Sylvester, please call 305-243-3329 or
email Survivorship Research.


To learn more or request an appointment, call 305-243-4922 or
email Survivorship Care.

Research FAQs

What is Cancer Survivorship Research? Page 1
What are examples of Cancer Survivorship Research? Page 1
What is Translational Behavioral Science? Page 1

Survivorship Provider Learning Series

As part of the Survivorship Provider Learning series, we invite experts in relevant cancer survivorship-related fields to bring knowledge and awareness to medical providers in order to better serve their patients’ survivorship needs. Experts range from clinical specialties to research investigators in order to expose providers to survivorship topics of interest.

We also offer educational modules intended for primary care providers when working with oncology patients in specific site disease groups including diversity, survivorship care, and available resources.

In-Service Provider – Past Speakers Page 1
Distinguished Speaker Series Page 1
Invited Speakers Page 1

Survivorship Pilot Program

Competitive funding for pilot studies is offered as a part of the Cancer Survivorship and Translational Behavioral Sciences Program.

These awards:

  • increase research in cancer survivorship and translational behavioral sciences
  • foster the development of interdisciplinary research teams to focus on important problems in a novel, effective, and transformative manner
  • provide a pathway for investigators to generate preliminary information that will optimize their chances of successfully competing for national-level peer-reviewed funding (e.g., NIH, DoD and/or ACS funding)

Only applications that embody these elements and provide defined objectives in such relevant areas of future publications and grant applications will be considered.

Projects must focus on a problem relevant to cancer survivorship and be led or co-led by a member of the cancer control research program. Research questions must address a priority area listed below. Studies emphasizing translational work in collaboration with members from Sylvester's Tumor Biology and/or Cancer Epigenetics Programs will be prioritized.

Priority areas:

  • Symptom and toxicities measurement and management
  • Patient reported outcomes (PROs)
  • Electronic health record (EHR), bioinformatics and value-based models of cancer survivorship care
  • Health disparities in specific survivorship subgroups (e.g., LGBTQ, Hispanics, elderly, occupational)
  • Cardiometabolic health in cancer survivors
  • Translational science and dissemination and implementation research
  • Technology-supported behavioral and psychosocial interventions
  • Biobehavioral mechanisms in cancer survivorship outcomes (e.g., symptom burden)

Pilot funding opportunities are announced in the spring for funding to begin the next fiscal year.

For more information, visit the funding announcements website.

Sylvester Cancer Survivorship & Translational Behavioral Sciences